India has long been known as the “pharmacy of the world” for supplying affordable generic drugs and vaccines. But the country achieved a major milestone in pharmaceutical innovation last year: Nafithromycin (brand name Miqnaf), developed by India's Wockhardt with support from the Biotechnology Industry Research Assistance Council (BIRAC). This is...
Bharat Biotech Targets Antimicrobial Resistance
Based in Hyderabad, India, Bharat Biotech is expanding its vaccine portfolio with a focus on antimicrobial resistance (AMR), a growing global health challenge. The company, known internationally for developing Covaxin during the Covid-19 pandemic, is now working on vaccines designed to prevent hospital-acquired infections, particularly in patients undergoing surgeries. According...